IARC Handbooks of Cancer Prevention Series 1

Non-Steroidal Anti-Inflammatory Drugs

November 1997
More details
  • Publisher
    World Health Organization
  • Published
    1st November 1997
  • ISBN 9789283230014
  • Language English
  • Pages 202 pp.
  • Size 6.5" x 9.5"

The objective of the Handbooks programme is the preparation of critical reviews and evaluations of evidence on the cancer-preventive and other relevant properties of a wide range of potential cancer-preventive agents and strategies by international working groups of experts.

In this volume on non-steroidal anti-inflammatory drugs the following drugs are reviewed: Aspirin, Sulindac, Piroxicam and Indomethacin. For each drug, their chemical and physical characteristics, occurrence, production, use, analysis and human exposure, metabolism, kinetics and genetic variation are studied, as well as their cancer-preventive effects, other beneficial effects, carcinogenicity and other toxic effects. A summary of data and recommendations for research are provided at the end.

The International Agency for Research on Cancer

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.